Clinical trial NCT06347848: The Effect of Psychoeducation Focused on Reducing Internalized Stigma
Official title: The Effect of Psychoeducation Focused on Reducing Internalized Stigma in Individuals Diagnosed With Schizophrenia on Treatment Adherence and Internalized Stigma
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Schizophrenia
Treatment Adherence
Stigma, Social
Keywords: Schizophrenia
Treatment Adherence
Internalized Stigma
Psychoeducation
Lead sponsor: Istanbul University - Cerrahpasa
Sponsor class: OTHER
First posted: 2024-04-04
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Two parallel groups randomized control study
Primary purpose: SUPPORTIVE_CARE

Brief summary: In the fight against stigma, the focus should be on the education of individuals diagnosed with mental illness. Psychoeducation has an important place in the treatment and rehabilitation of mental health problems. Psychoeducation is necessary for early recognition of signs and symptoms of diseases, ensuring compliance with treatment, improving coping skills, as well as combating stigma, preventing internalized stigma, and counteracting social stigma. If individuals with mental disorders have adequate knowledge about the causes of stigma, they may be less prone to internalized stigma.

Detailed description: The group most exposed to stigma among mental illnesses is individuals diagnosed with schizophrenia. These individuals avoid treatment due to fear of stigma, which creates a significant obstacle to ensuring their well-being. Internalization of stigma causes feelings of loneliness, anger, helplessness, deterioration in quality of life, and decrease in self-esteem, while at the same time creating a significant barrier to treatment compliance. Compliance problems with treatment: It causes impairments in functionality, relapses and exacerbations, repeated hospitalizations, adverse effects on quality of life and increased mortality rates. The fact that many patients who receive only medical treatment in the treatment of schizophrenia develop negative attitudes towards drug use due to drug side effects and recurrence of disease symptoms reveals that psychosocial approaches should also be given importance in addition to medical treatment. As a result, it is thought that internalized stigma is a significant obstacle to treatment compliance and practices implemented to reduce internalized stigma are effective in increasing treatment compliance.

Eligibility criteria: Inclusion Criteria:

* Volunteer to participate in the research,
* Diagnosed with schizophrenia according to DSM-V TR diagnostic criteria,
* Over 18 years old,
* Being in remission for 2 months,
* At least primary school graduate,
* Residing in Edirne city center and its districts,
* Individuals without hearing or understanding problems.

Exclusion Criteria:

* Not meeting the inclusion criteria,
* Having a diagnosis of dementia or other organic mental disorder as an additional diagnosis,
* Individuals with a history of substance abuse (other than nicotine).

Primary outcomes:
measure: Internalized Stigma of Mental Illness Scale
timeFrame: 4 Month
measure: Medication Adherence Reporting Scale
timeFrame: 4 Month
Secondary outcomes:
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Istanbul University - Cerrahpasa (IUC)
state: Şişli
Study officials:
affiliation: Istanbul University - Cerrahpasa
name: Ozge SUKUT, PhD
role: STUDY_DIRECTOR
References: